InvestorsHub Logo
Followers 2
Posts 1274
Boards Moderated 0
Alias Born 08/09/2013

Re: catty post# 6211

Sunday, 01/08/2017 11:11:16 AM

Sunday, January 08, 2017 11:11:16 AM

Post# of 14857
Unimed in Takeover Talks
By BLOOMBERG NEWSMAY 29, 1999
Continue reading the main storyShare This Page
Share
Tweet
Email
More
Save
Unimed Pharmaceuticals Inc. said today that it was in negotiations to sell all outstanding shares of the company to an unnamed third party. The sale will be handled by Hambrecht & Quist. Trading in the shares was halted before the announcement. Earlier, the stock rose to a 52-week high of $9.25, valuing the company at $84 million. Since the beginning of the year, Unimed's stock price has more than doubled. The company focuses on therapies for cancer and H.I.V. It markets three drugs, including the H.I.V. and cancer treatment Marinol, the only drug to contain THC, the active ingredient in marijuana. Unimed had revenue of $16 million in 1998.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News